首頁 > 市場調查報告書 > 醫療設備

心血管設備電子醫療設備

市場調查報告書

商品編碼

2087984

心血管器材：2030 年全球市場展望

Cardiovascular Devices: Global Markets to 2030

出版日期: 2026年07月02日 | 出版商:

BCC Research | 英文 170 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球心血管設備市場預計將從 2025 年的 724 億美元成長到 2030 年底的 1,016 億美元，在 2025 年至 2030 年的預測期內，複合年成長率將達到 7.0%。

調查範圍

本報告概述了全球心血管器械市場，並分析了市場趨勢。報告包括以2024年為基準年的全球銷售額（百萬美元）、2025年的估計數據以及2026年至2030年的預測數據。

該市場按產品和最終用戶進行細分。按產品分類，心血管器械市場可細分為介入性心臟病學、心臟節律管理、診斷和監測、心臟輔助裝置、電生理學等血管外科器械。按最終用戶分類，市場可細分為醫院和診所、門診手術中心、診斷檢查室以及其他最終用戶。本研究涵蓋的地區包括北美（美國、加拿大、墨西哥）、歐洲（德國、英國、英國、法國、西班牙及其他歐洲國家）、亞太地區（中國、日本、印度、韓國、澳洲及其他亞太國家）、中東和非洲以及南美洲，重點關注這些地區的所有主要國家。

本報告重點在於影響市場和供應商格局的關鍵促進因素和挑戰，並對與市場相關的新興技術進行分析和探討。

本報告最後分析了競爭格局，並概述了全球領先的心血管器材公司。報告也特別闢出一節介紹各公司的概況，涵蓋主要參與者、關鍵財務指標、產品系列和最新發展動態。

本報告內容

資料表 69 及補充表 73
全球心血管器材市場概況與分析
全球趨勢分析，包括 2022 年至 2025 年的銷售數據以及到 2030 年的複合年成長率預測。
對當前市場規模和未來銷售成長預測進行估算，並按產品、最終用戶和地區進行市場佔有率分析。
有關市場動態的事實和數據，包括主要市場促進因素、市場限制、機會、挑戰以及宏觀經濟因素的影響。
對重點地區的法規結構進行概述，並評估核准流程和合規要求。
深入了解新興技術和發展趨勢，包括微創設備、遠端患者監護和植入式心血管技術的創新。
專利分析，重點關注與心血管器械相關的已註冊和已公佈的主要專利。
競爭格局的分析，包括公司市佔率排名、策略舉措、合作夥伴關係和最新發展。
全球心血管器材市場永續發展趨勢及ESG進展概述
包括Medtronic、雅培、波士頓科學、愛德華生命科學和強生在內的全球領先公司的概述。

市場動態
市場促進因素
心血管疾病和其他文明病的盛行率增加
心血管治療領域對微創手術的需求日益成長
擴大遠端患者監護在心臟病管理的應用
市場限制因素
嚴格的產品核可准則
先進心血管器械和手術高成本。
市場機遇
對預防性和早期診斷解決方案的需求日益成長
人們對以價值為導向的醫療保健越來越感興趣。
市場挑戰
複雜產品開發
植入式醫療設備相關併發症

第4章監管情勢

美國
歐洲
其他地區

第5章：新興科技與趨勢

新興技術
無導線無線心臟植入
生物可吸收心臟醫療設備
穿戴式心臟裝置
全人工心臟
人工智慧
專利分析
專利（按年份）
由頂級安裝人員撰寫
由主要所有者
按管轄權

第6章市場區隔分析

細分市場
市場分析：按產品分類
介入性心臟病學
心律管理
診斷和監測
心臟輔助裝置
電生理學
其他心血管裝置
市場分析：依最終用戶分類
醫院和診所
門診手術中心
診斷檢查室
其他最終用戶
按地區分類
市場分析：按地區分類
北美洲
歐洲
亞太地區
南美洲
中東和非洲（MEA）

第7章競爭情勢

競爭格局
全球市場領導企業
Medtronic
Abbott
Boston Scientific Corp
Edward
Johnson & Johnson
關鍵發展和策略

第8章附錄

調查方法
資訊來源
簡稱
公司簡介
ABBOTT
BAXTER
B. BRAUN SE
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BPL MEDICAL TECHNOLOGIES
COOK
EDWARDS LIFESCIENCES CORP.
GE HEALTHCARE
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
MEDTRONIC
NIHON KOHDEN CORP.
SIEMENS HEALTHINEERS AG
TERUMO CORP.
新興創業公司/市場顛覆者

簡介目錄圖表

Product Code: HLC210B

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global cardiovascular devices market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented by product and end user. Based on product, the cardiovascular devices market is segmented into interventional cardiology, cardiac rhythm management, diagnostics and monitoring, cardiac assist devices, electrophysiology, and other vascular surgery devices. Based on end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading global cardiovascular devices companies. It also includes a dedicated section of company profiles that covers overviews, key financials, product portfolios, and recent developments for major companies.

Report Includes

69 data tables and 73 additional tables
An overview and analysis of the global cardiovascular devices market
Analyses of global market trends, with revenue data for 2022-2025, and projections of CAGRs through 2030
Estimates of the current market size and future revenue growth prospects, accompanied by a market share analysis by product, end user, and region
Facts and figures pertaining to market dynamics, including key drivers, restraints, opportunities, challenges, and the impact of macroeconomic factors
Review of regulatory frameworks across major regions, along with an assessment of approval pathways and compliance requirements
Insights into emerging technologies and developments, including innovations in minimally invasive devices, remote patient monitoring, and implantable cardiovascular technologies
Patent analysis highlighting key granted and published patents related to cardiovascular medical devices
Analysis of the competitive landscape, including company market share rankings, strategic initiatives, partnerships, and recent developments
Overview of sustainability trends and ESG developments in the global cardiovascular devices market
Profiles of the leading global companies, including Medtronic, Abbott, Boston Scientific Corp., Edwards Lifesciences Corp., and Johnson & Johnson

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion

Chapter 2 Market Overview

Overview
Type of Cardiovascular Diseases
Coronary Artery Disease
Arrhythmia
Structural Heart Disease
Heart Infection
Cardiovascular Procedures Volume
Cardiovascular Procedures Cost
Porter's Five Forces Analysis in the Technologies for Cardiovascular Devices Market
Potential for New Entrants (Low to Moderate)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low)
Competition in the Industry (High)
Macroeconomic Factor Analysis
Urbanization and Lifestyle Changes
Shortage of Skilled Professionals
U.S. Tariff Scenario

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rising Prevalence of Cardiovascular Disorders and Other Lifestyle-Related Disorders
Growing Demand for Minimally Invasive Procedures in Cardiovascular Treatment
Increasing Adoption of Remote Patient Monitoring for Cardiac Disease Management
Market Restraints
Stringent Product Approval Guidelines
High Cost of Advanced Cardiovascular Devices and Procedures
Market Opportunities
Growing Demand for Preventive and Early-Diagnosis Solutions
Increasing Focus on Value-Based Healthcare
Market Challenges
Complex Product Development
Complications Associated with Implantable Devices

Chapter 4 Regulatory Landscape

U.S.
Europe
Other Regions

Chapter 5 Emerging Technologies and Developments

Emerging Technologies
Leadless and Wireless Cardiac Implants
Bioresorbable Cardiac Devices
Wearable Cardiac Devices
Total Artificial Heart
Artificial Intelligence
Patent Analysis
Key Takeaways
Patents, by Year
By Top Applicant
By Top Owner
By Jurisdiction

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Product
Key Takeaways
Interventional Cardiology
Cardiac Rhythm Management
Diagnostics and Monitoring
Cardiac Assist Devices
Electrophysiology
Other Vascular Surgery Devices
Market Analysis by End User
Key Takeaways
Hospitals and Clinics
Ambulatory Surgical Centers
Diagnostics Laboratories
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Landscape
Leading Companies in the Global Cardiovascular Devices Market
Medtronic
Abbott
Boston Scientific Corp
Edward
Johnson & Johnson
Key Developments and Strategies

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
BAXTER
B. BRAUN SE
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BPL MEDICAL TECHNOLOGIES
COOK
EDWARDS LIFESCIENCES CORP.
GE HEALTHCARE
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
NIHON KOHDEN CORP.
SIEMENS HEALTHINEERS AG
TERUMO CORP.
Few Emerging Start-Ups/ Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for Cardiovascular Devices, by Region, Through 2030
Table 1 : Cardiovascular Diseases: Modifiable Risk Factors
Table 2 : Global: Annual Cardiac Surgical Volumes per 100,000 Population Per Year
Table 3 : Cost of Cardiovascular Surgery, by Country, 2025
Table 4 : Porter's Five Forces Analysis: Overview
Table 5 : Global Cardiovascular Disease: Prevalence and Deaths, 2023
Table 6 : Advantages of Remote Patient Monitoring
Table 7 : Cardiovascular Care Programs Driving Value-Based Outcomes and Cost Efficiency
Table 8 : Complications Associated with Implantable Devices
Table 9 : FDA Regulatory Pathways and Cardiovascular Device Classification Overview
Table 10 : EU Medical Device Regulatory Pathway
Table 11 : Other Region: Cardiovascular Regulatory Landscape
Table 12 : List of Wearable Cardiac Devices
Table 13 : Total Artificial Heart, Company Comparison, 2026
Table 14 : AI in Cardiology: Application
Table 15 : Patents, by Top Applicant, 2022-2025
Table 16 : Patents, by Top Owner, 2022-2025
Table 17 : Patents, by Jurisdiction, 2022-2025
Table 18 : Global Market for Cardiovascular Devices Market, by Product, Through 2030
Table 19 : TAVR Systems, by Company
Table 20 : TMVR Systems, by Company
Table 21 : Major Catheters in Interventional Cardiology
Table 22 : Type of Cardiovascular Stent
Table 23 : Advances in Drug-Eluting Stents
Table 24 : Global Market for Interventional Cardiology, by Type, Through 2030
Table 25 : Pacemaker, by Company
Table 26 : Advances in Pacemakers
Table 27 : CRT Devices, by Company
Table 28 : ICD Devices, by Company
Table 29 : Global Market for Cardiac Rhythm Management, by Type, Through 2030
Table 30 : Different Types of ECG
Table 31 : ECG Products, by Type
Table 32 : Different Types of Echocardiographs
Table 33 : Echocardiograph, by Company
Table 34 : Global Market for Diagnostics and Monitoring, by Type, Through 2030
Table 35 : Ventricular Assist Device, by Company
Table 36 : Intra-Aortic Balloon Pump, by Company
Table 37 : Global Market for Cardiac Assist Devices, by Type, Through 2030
Table 38 : Global Market for Electrophysiology, by Type, Through 2030
Table 39 : Global Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 40 : Global Market for Cardiovascular Devices, by End User, Through 2030
Table 41 : Global Market for Cardiovascular Devices, by Region, Through 2030
Table 42 : North American Market for Cardiovascular Devices, by Country, Through 2030
Table 43 : North American Market for Cardiovascular Devices, by Product, Through 2030
Table 44 : North American Market for Interventional Cardiology, by Type, Through 2030
Table 45 : North American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 46 : North American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 47 : North American Market for Cardiac Assist Devices, by Type, Through 2030
Table 48 : North American Market for Electrophysiology, by Type, Through 2030
Table 49 : North American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 50 : North American Market for Cardiovascular Devices, by End User, Through 2030
Table 51 : European Market for Cardiovascular Devices, by Country, Through 2030
Table 52 : European Market for Cardiovascular Devices, by Product, Through 2030
Table 53 : European Market for Interventional Cardiology, by Type, Through 2030
Table 54 : European Market for Cardiac Rhythm Management, by Type, Through 2030
Table 55 : European Market for Diagnostics and Monitoring, by Type, Through 2030
Table 56 : European Market for Cardiac Assist Devices, by Type, Through 2030
Table 57 : European Market for Electrophysiology, by Type, Through 2030
Table 58 : European Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 59 : European Market for Cardiovascular Devices, by End User, Through 2030
Table 60 : Asia-Pacific Market for Cardiovascular Devices, by Country, Through 2030
Table 61 : Asia-Pacific Market for Cardiovascular Devices, by Product, Through 2030
Table 62 : Asia-Pacific Market for Interventional Cardiology, by Type, Through 2030
Table 63 : Asia-Pacific Market for Cardiac Rhythm Management, by Type, Through 2030
Table 64 : Asia-Pacific Market for Diagnostics and Monitoring, by Type, Through 2030
Table 65 : Asia-Pacific Market for Cardiac Assist Devices, by Type, Through 2030
Table 66 : Asia-Pacific Market for Electrophysiology, by Type, Through 2030
Table 67 : Asia-Pacific Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 68 : Asia-Pacific Market for Cardiovascular Devices, by End User, Through 2030
Table 69 : South American Market for Cardiovascular Devices, by Product, Through 2030
Table 70 : South American Market for Interventional Cardiology, by Type, Through 2030
Table 71 : South American Market for Cardiac Rhythm Management, by Type, Through 2030
Table 72 : South American Market for Diagnostics and Monitoring, by Type, Through 2030
Table 73 : South American Market for Cardiac Assist Devices, by Type, Through 2030
Table 74 : South American Market for Electrophysiology, by Type, Through 2030
Table 75 : South American Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 76 : South American Market for Cardiovascular Devices, by End User, Through 2030
Table 77 : MEA Market for Cardiovascular Devices, by Product, Through 2030
Table 78 : MEA Market for Interventional Cardiology, by Type, Through 2030
Table 79 : MEA Market for Cardiac Rhythm Management, by Type, Through 2030
Table 80 : MEA Market for Diagnostics and Monitoring, by Type, Through 2030
Table 81 : MEA Market for Cardiac Assist Devices, by Type, Through 2030
Table 82 : MEA Market for Electrophysiology, by Type, Through 2030
Table 83 : MEA Market for Other Vascular Surgery Devices, by Type, Through 2030
Table 84 : MEA Market for Cardiovascular Devices, by End User, Through 2030
Table 85 : Global Market Share Analysis for Cardiovascular Devices, by Company, 2024
Table 86 : Cardiovascular Devices: Recent Strategic Developments, 2024-2026
Table 87 : Report Information Sources
Table 88 : Abbreviations Used in the Cardiovascular Devices Market Report
Table 89 : Abbott: Company Snapshot
Table 90 : Abbott: Financial Performance, FY 2023 and 2024
Table 91 : Abbott: Product Portfolio
Table 92 : Abbott: News/Key Developments, 2023-2025
Table 93 : Baxter: Company Snapshot
Table 94 : Baxter: Financial Performance, FY 2023 and 2024
Table 95 : Baxter: Product Portfolio
Table 96 : B. Braun SE: Company Snapshot
Table 97 : B. Braun SE: Financial Performance, FY 2023 and 2024
Table 98 : B. Braun SE: Product Portfolio
Table 99 : Biotronik: Company Snapshot
Table 100 : Biotronik: Product Portfolio
Table 101 : Biotronik: News/Key Developments, 2023-2025
Table 102 : Boston Scientific Corp.: Company Snapshot
Table 103 : Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 104 : Boston Scientific Corp.: Product Portfolio
Table 105 : Boston Scientific Corp.: News/Key Developments, 2024-2026
Table 106 : BPL Medical Technologies: Company Snapshot
Table 107 : BPL Medical Technologies: Product Portfolio
Table 108 : Cook: Company Snapshot
Table 109 : Cook: Product Portfolio
Table 110 : Edwards Lifesciences Corp.: Company Snapshot
Table 111 : Edwards Lifesciences Corp.: Financial Performance, FY 2023 and 2024
Table 112 : Edwards Lifesciences Corp.: Product Portfolio
Table 113 : Edwards Lifesciences Corp.: News/Key Developments, 2024-2025
Table 114 : GE HealthCare: Company Snapshot
Table 115 : GE HealthCare: Financial Performance, FY 2023 and 2024
Table 116 : GE HealthCare: Product Portfolio
Table 117 : GE HealthCare: News/Key Developments, 2023
Table 118 : Johnson & Johnson: Company Snapshot
Table 119 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 120 : Johnson & Johnson: Product Portfolio
Table 121 : Johnson & Johnson: News/Key Developments, 2023-2025
Table 122 : Koninklijke Philips N.V.: Company Snapshot
Table 123 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 124 : Koninklijke Philips N.V.: Product Portfolio
Table 125 : Medtronic: Company Snapshot
Table 126 : Medtronic: Financial Performance, FY 2023 and 2024
Table 127 : Medtronic: Product Portfolio
Table 128 : Medtronic: News/Key Developments, 2023-2025
Table 129 : Nihon Kohden Corp.: Company Snapshot
Table 130 : Nihon Kohden Corp.: Financial Performance, FY 2023 and 2024
Table 131 : Nihon Kohden Corp.: Product Portfolio
Table 132 : Nihon Kohden Corp.: News/Key Developments, 2024
Table 133 : Siemens Healthineers AG: Company Snapshot
Table 134 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 135 : Siemens Healthineers AG: Product Portfolio
Table 136 : Siemens Healthineers AG: News/Key Developments, 2023
Table 137 : Terumo Corp.: Company Snapshot
Table 138 : Terumo Corp.: Financial Performance, FY 2023 and 2024
Table 139 : Terumo Corp.: Product Portfolio
Table 140 : Terumo Corp.: News/Key Developments, 2025
Table 141 : List of a Few Emerging Start-Ups/ Market Disruptors

List of Figures

Summary Figure : Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 1 : Heart Bypass Surgery Cost Structure, India, 2025
Figure 2 : Porter's Five Forces Analysis of the Technologies for Cardiovascular Devices Market
Figure 3 : Snapshot of Market Dynamics of Cardiovascular Devices
Figure 4 : Advantages of Minimally Invasive Procedures in Cardiovascular Treatment
Figure 5 : CARDIOLOGY: Remote Patient Monitoring Solutions
Figure 6 : Challenges in Cardiovascular Device Manufacturing
Figure 7 : Emerging Trends/Technologies in the Cardiovascular Devices Market
Figure 8 : Patents Granted, by Year, 2022-2025
Figure 9 : Global Market Shares of Cardiovascular Devices, by Product, 2024
Figure 10 : Global Market Shares of Cardiovascular Devices, by End User, 2024
Figure 11 : Global Market Shares of Cardiovascular Devices, by Region, 2024
Figure 12 : North American Market Shares of Cardiovascular Devices, by Country, 2024
Figure 13 : European Market Shares of Cardiovascular Devices, by Country, 2024
Figure 14 : Asia-Pacific Market Shares of Cardiovascular Devices, by Country, 2024
Figure 15 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 16 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 17 : Baxter: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Baxter: Revenue Shares, by Country/Region, FY 2024
Figure 19 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 20 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 21 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 22 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Edwards Lifesciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 24 : Edwards Lifesciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 25 : GE HealthCare: Revenue Shares, by Business Unit, FY 2024
Figure 26 : GE HealthCare: Revenue Shares, by Country/Region, FY 2024
Figure 27 : Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
Figure 28 : Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
Figure 29 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2024
Figure 30 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2024
Figure 31 : Medtronic: Revenue Shares, by Business Unit, FY 2024
Figure 32 : Medtronic: Revenue Shares, by Region/Country, FY 2024
Figure 33 : Nihon Kohden Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 34 : Nihon Kohden Corp.: Revenue Shares, by Region/Country, FY 2024
Figure 35 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 36 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
Figure 37 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 38 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2024